IGC Pharma, Inc.IGCNYSE
Loading
Year-over-year gross profit growth rate
Latest
-106.06%
↓ 241% vs avg
Percentile
P8
Near historical low
Streak
3 qtr
Consecutive declineDecelerating
Average
75.08%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -106.06% |
| Q3 2025 | -35.71% |
| Q2 2025 | 0.00% |
| Q1 2025 | 48.08% |
| Q4 2024 | -47.47% |
| Q3 2024 | 21.47% |
| Q2 2024 | 552.00% |
| Q1 2024 | 457.14% |
| Q4 2023 | -104.02% |
| Q3 2023 | 47.46% |
| Q2 2023 | 87.30% |
| Q1 2023 | 212.50% |
| Q4 2022 | -141.48% |
| Q3 2022 | 1450.00% |
| Q2 2022 | -114.71% |
| Q1 2022 | 9.68% |
| Q4 2021 | 63.16% |
| Q3 2021 | 46.15% |
| Q2 2021 | -3.70% |
| Q1 2021 | 92.86% |
| Q4 2020 | -46.15% |
| Q3 2020 | -43.48% |
| Q2 2020 | 187.50% |
| Q1 2020 | -46.67% |
| Q4 2019 | 7.14% |
| Q3 2019 | -31.71% |
| Q2 2019 | 51.85% |
| Q1 2019 | -40.00% |
| Q4 2018 | 150.00% |
| Q3 2018 | -57.08% |
| Q2 2018 | 155.23% |
| Q1 2018 | -295.00% |
| Q4 2017 | -46.26% |
| Q3 2017 | 57.40% |
| Q2 2017 | 536.26% |
| Q1 2017 | -94.35% |
| Q4 2016 | 78.70% |
| Q3 2016 | -17.32% |
| Q2 2016 | -67.61% |
| Q1 2016 | 29.97% |